Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags News Health Care Trading Ideas
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags BMY JNJ Market News
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags Market News BMY CATX
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags General RVPH Schizophrenia
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags BMY Analyst Ratings BZI/AAR
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags MRNA Market News HIMS
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags Top Stories GOOG SPY
From Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Tickers BMY CRM PFE
Tags General Expert Ideas Technicals
From Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Tickers BMY NEWS
Tags General FDA Briefs
From Benzinga
2 Passive-Income Stocks to Load Up On in October
Tickers BMY LMT
Tags BMY Recent Press Releases Market News
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
Tickers BMY
Tags Options Benzinga BZI/UOA
From Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
Tickers BMY IGMS NEWS
Tags Management General Movers
From Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Tickers BMY PRME
Tags BMY PRME Recent Press Releases
From Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Tickers BMY NEWS PRME
Tags General PRME Stories That Matter
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
Tickers BMY MRNA PFE
Tags BMY PFE Recent Press Releases
From Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Tickers ABBV BMY NEWS
Tags Biotech Movers Benzinga
From Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
Tickers BABA BHP BMY BP
Tags BABA News EQNR
From Benzinga
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Tickers BMY NEWS PRTC
Tags Health Care Trading Ideas Large Cap
From Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Tickers ATCH BMY CDIO DUO
Tags DUO CDIO SOAR
From Benzinga
Wall Street On Wait-And-Watch Mode Ahead Of Inflation Data, Bitcoin Holds Above 65.5K: Analyst Says Volatility Ahead Providing Better Entry Point Into Long-term Bull Market
Tickers BB BITCOMP BMY COST
Tags Benzinga Media bitcoin
From Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Tickers BGNE BMY MRK NEWS
Tags Benzinga Stories That Matter Biotech
From Benzinga
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
Tickers BMY NEWS NVO TSVT
Tags General TSVT Briefs
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers BHVN BMY BNTX CI
Tags BNTX GMED Market News
From Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Tickers ABBV BMY NEWS
Tags Large Cap News Top Stories
From Benzinga
Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy
Tickers BMY NEWS
Tags BMY General Market News
From Benzinga
What Analysts Are Saying About Bristol-Myers Squibb Stock
Tickers BMY
Tags BZI/AAR Analyst Ratings BMY
From Benzinga
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
Tickers BEP BMY RPRX
Tags BMY RPRX BEP
From Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Tickers BMY GILD
Tags BMY GILD Market News
From Motley Fool
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
Tickers BIIB BMY NEWS
Tags Benzinga healthcare Sanders
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags BMY RHHBY AZN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.